Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Taxotere

44523740_l

Taxotere (docetaxel) is a chemotherapy drug, used to treat cancer. It is one of the most commonly used chemotherapy drugs for breast cancer, and it is also used for other types of cancer. Like other chemotherapy drugs, Taxotere can cause severe side effects, including vomiting, joint or muscle pain, and compromised immune system. The side effects are usually, but not always, temporary. Taxotere causes permanent hair loss in some patients.

What is Taxotere?

Taxotere is an anti-cancer chemotherapy drug, also referred to as an antineoplastic or cytotoxic chemotherapy drug. It is in a class of drugs, called taxanes, which interfere with the ability of cancer cells to divide. Taxanes are plant alkaloids made from the bark of the Pacific Yew tree (taxus).

Taxotere Uses

Taxotere has been approved by the U.S. Food and Drug Administration (FDA) to treat:

  • Breast cancer
  • Non-small cell lung cancer
  • Advanced stomach cancer
  • Head and neck cancer
  • Metastatic prostate cancer

It is being investigated to treat:

  • Small cell lung cancer
  • Ovarian cancer
  • Bladder cancer
  • Pancreatic cancer
  • Soft tissue sarcoma
  • Melanoma

Taxotere is often given in combination with other chemotherapy drugs.

Taxotere Side Effects

According to Chemocare, the most common side effects of Taxotere, affecting more than 30% of patients, include:

  • Low white blood cell count, which increases risk of infection
  • Anemia – low red blood cell count
  • Fluid retention with weight gain, swelling of the ankles or abdominal area.
  • Peripheral neuropathy (numbness in your fingers and toes) may occur with repeated doses. This should be reported to your healthcare provider.
  • Nausea
  • Diarrhea
  • Mouth sores
  • Hair loss
  • Fatigue and weakness
  • Infection
  • Nail changes (color changes to your fingernails or toenails may occur while taking Taxotere. In extreme, but rare, cases nails may fall off. After you have finished Taxotere treatments, your nails will generally grow back.)

Also according to Chemocare, about 10% to 29% of people using Taxotere experience:

  • Vomiting
  • Muscle pain
  • Bone pain
  • Joint pain
  • Low platelet count, which increases risk of bleeding
  • Elevated levels on liver tests

Taxotere can also cause:

  • Constipation
  • Taste changes
  • Watery eyes
  • Allergic reactions
  • Irregular periods in women, sometimes including permanent cessation of periods

Dangerous Adverse Events

The most dangerous potential side effects of Taxotere include:

  • Toxic deaths
  • Hepatotoxicity
  • Neutropenia
  • Hypersensitivity reactions
  • Fluid retention

These reactions are rare and are most likely in certain patients including those with abnormal liver function.

Taxotere and Permanent Hair Loss

Temporary hair loss is a very common side effect of chemotherapy. However, studies have found a six to 10% chance of permanent hair loss with Taxotere. Permanent hair loss, especially when unexpected and unexplained, can have a devastating emotional effect on cancer survivors.

If you have questions about Taxotere that are not answered here or believe your permanent hair loss was caused by Taxotere, please contact us for a free case evaluation.  We will help you find answers to your questions and we can refer you to an attorney who represents Taxotere victims.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

Taxotere Resources

  • Taxotere Manufatures Page
  • Taxotere on Wikipedia
  • Taxotere on WebMD
  • Taxotere on Drugs.com
  • Taxotere on BrestCancer.org

Videos

  • Understanding Your Taxotere Treatment
  • Coping with Permanent Hair Loss
  • Chemotherapy Drug Linked to Hair Loss
  • Chemotherapy Drug Linked to More Suffering

RSS FDA Med Watch

  • FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication
  • FDA Advises Consumers, Tattoo Artists, and Retailers to Avoid Using or Selling Certain Sacred Tattoo Ink Products Contaminated with Microorganisms
  • EnShiShiXiangNiShangMaoYouXianGongSi Issues Voluntary Nationwide Recall of ENDURANCE BOOST WITH HORNY GOAT WEED Capsules Due To Presence of Undeclared Propoxyphenylsildenafil and Sildenafil
  • Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
  • Risk of False Positive Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
  • Early Alert: Intravascular PICC Catheter Issue from BD
  • Early Alert: Diagnostic Intravascular Catheter Issue from Conavi

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Health Industry

  • IPO Pipeline Restarts As Tariff-Related Volatility Eases
  • J&J Unit Hit With $147M Verdict In Catheter Antitrust Suit
  • Fla. Gov. Says He Will Veto Bill To Expand Death Damages

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in